We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
(+18%)
Cap. Flow
+$342M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$163M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$137M |
| 3 |
Repligen
RGEN
|
+$104M |
| 4 |
Biogen
BIIB
|
+$104M |
| 5 |
Zoetis
ZTS
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 2 |
Agilent Technologies
A
|
+$137M |
| 3 |
Fidelity National Information Services
FIS
|
+$86.2M |
| 4 |
Adobe
ADBE
|
+$76.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.24% |
| 2 | Consumer Discretionary | 12.89% |
| 3 | Financials | 10.77% |
| 4 | Technology | 9.62% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Astrana Health
ASTH
$1.88B
| $244K | ﹤0.01% |
13,362
-2,422
| -15% | -$43.5K |
|
1702
Houlihan Lokey
HLI
$10.2B
| $243K | ﹤0.01% |
+3,609
| New | +$234K |
|
|
MYOV
1703
DELISTED
Myovant Sciences Ltd.
MYOV
| $238K | ﹤0.01% |
+8,630
| New | +$168K |
|
1704
Verizon
VZ
$201B
| $237K | ﹤0.01% |
4,027
-181,768
| -98% | -$10.8M |
|
1705
Plains GP Holdings
PAGP
$5.2B
| $235K | ﹤0.01% |
+27,810
| New | +$216K |
|
|
NHIC
1706
DELISTED
NewHold Investment Corp. Class A Common Stock
NHIC
| $235K | ﹤0.01% |
+23,436
| New | +$230K |
|
|
LEAF
1707
DELISTED
Leaf Group Ltd.
LEAF
| $235K | ﹤0.01% |
+50,601
| New | +$279K |
|
1708
Western Midstream Partners
WES
$19.4B
| $234K | ﹤0.01% |
+16,885
| New | +$194K |
|
1709
Gold Fields
GFI
$29.2B
| $233K | ﹤0.01% |
+25,164
| New | +$266K |
|
1710
NRC Health Common Stock
NRC
$503M
| $233K | ﹤0.01% |
+5,454
| New | +$280K |
|
|
SBOW
1711
DELISTED
SilverBow Resources, Inc.
SBOW
| $233K | ﹤0.01% |
43,867
-1,814
| -4% | -$9.28K |
|
1712
ACM Research
ACMR
$4.98B
| $232K | ﹤0.01% |
+8,553
| New | +$219K |
|
1713
HSBC
HSBC
$356B
| $232K | ﹤0.01% |
+8,961
| New | +$213K |
|
|
SAFE
1714
DELISTED
Safehold Inc.
SAFE
| $232K | ﹤0.01% |
+3,200
| New | +$218K |
|
|
ALLK
1715
DELISTED
Allakos
ALLK
| $231K | ﹤0.01% |
+1,647
| New | +$171K |
|
1716
Farmers National Banc Corp
FMNB
$947M
| $231K | ﹤0.01% |
17,383
-5,593
| -24% | -$69.9K |
|
|
THWWW
1717
CALL
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
| $231K | ﹤0.01% |
+146,041
| New | +$10.4K |
|
1718
Commerce Bancshares
CBSH
$8.64B
| $225K | ﹤0.01% |
+4,364
| New | +$211K |
|
1719
Envista
NVST
$4.39B
| $225K | ﹤0.01% |
6,674
-70,956
| -91% | -$2.06M |
|
1720
Kaiser Aluminum
KALU
$2.65B
| $224K | ﹤0.01% |
+2,268
| New | +$174K |
|
1721
Oshkosh
OSK
$9.51B
| $222K | ﹤0.01% |
+2,584
| New | +$206K |
|
1722
World Kinect Corp
WKC
$2.06B
| $222K | ﹤0.01% |
+7,116
| New | +$190K |
|
1723
CubeSmart
CUBE
$9.62B
| $220K | ﹤0.01% |
+6,532
| New | +$219K |
|
1724
Oaktree Specialty Lending
OCSL
$1.06B
| $220K | ﹤0.01% |
13,137
-8,816
| -40% | -$137K |
|
|
MNRL
1725
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $219K | ﹤0.01% |
19,945
-48,051
| -71% | -$496K |
|
Similar funds
Marshall Wace's Q4 2020 Portfolio in Review
As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
- Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
- Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
- Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
- Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
- Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
- Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.